人工智能在乳腺病理学中的应用
本文综述了人工智能在乳腺病理学中的应用进展,涵盖全切片成像与数字工作流背景下的诊断、分级、淋巴结转移检测、生物标志物定量、预后与治疗反应预测及分子改变预测,并讨论了当前与潜在应用的成功与挑战。
要点
- AI可辅助乳腺病理诊断,提高准确性并减少病理医生工作量。
- AI应用涵盖乳腺癌诊断分级、淋巴结转移检测和生物标志物定量。
- AI还能提供预后与治疗反应预测及潜在分子改变预测的新信息。
核心结论
- 随着在乳腺病理学中应用的增加,AI不仅辅助病理诊断以提高准确性并减少病理医生工作量,还提供预后与治疗反应预测的新信息。
研究设计与样本
- 通过检索和回顾PubMed中关于乳腺病理学AI的文献并结合自身经验,提供最新综述。
主要发现
- AI算法的发展为满足乳腺病理学需求提供了有前景的方法。
- 综述考察了当前和潜在AI应用在诊断和分级乳腺癌及其他病理改变、检测淋巴结转移、量化乳腺癌生物标志物、预测预后和治疗反应以及预测潜在分子改变方面的成功与挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Increasing implementation of whole slide imaging together with digital workflow and advances in computing capacity enable the use of artificial intelligence (AI) in pathology, including breast pathology. Breast pathologists often face a significant workload, with diagnosis complexity, tedious repetitive tasks, and semiquantitative evaluation of biomarkers. Recent advances in developing AI algorithms have provided promising approaches to meet the demand in breast pathology. OBJECTIVE.—: To provide an updated review of AI in breast pathology. We examined the success and challenges of current and potential AI applications in diagnosing and grading breast carcinomas and other pathologic changes, detecting lymph node metastasis, quantifying breast cancer biomarkers, predicting prognosis and therapy response, and predicting potential molecular changes. DATA SOURCES.—: We obtained data and information by searching and reviewing literature on AI in breast pathology from PubMed and based our own experience. CONCLUSIONS.—: With the increasing application in breast pathology, AI not only assists in pathology diagnosis to improve accuracy and reduce pathologists' workload, but also provides new information in predicting prognosis and therapy response.
引用
- Liu Y, Han D, Parwani AV, et al. Applications of Artificial Intelligence in Breast Pathology. Arch Pathol Lab Med. 2023. PMID: 36800539. doi:10.5858/arpa.2022-0457-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。